4//SEC Filing
PAULSON & CO. INC. 4
Accession 0001013594-25-001474
CIK 0000885590other
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 5:38 PM ET
Size
6.1 KB
Accession
0001013594-25-001474
Insider Transaction Report
Form 4
PAULSON & CO INC
10% Owner
Transactions
- Purchase
Common Stock, no par value
2025-11-25$6.25/sh+2,500,000$15,625,000→ 73,255,869 total(indirect: By Managed Funds)
Footnotes (1)
- [F1]Paulson & Co. ("Paulson") is the investment manager of certain investment funds (the "Funds"). John Paulson is the controlling person of Paulson. All securities reported on this Form 4 are owned by the Funds. Each of Paulson and John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any securities not directly owned by such reporting person.
Documents
Issuer
Bausch Health Companies Inc.
CIK 0000885590
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001035674
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 5:38 PM ET
- Size
- 6.1 KB